Globo H
Anti-Globo H Recombinant Antibody Products
-
- Type: Mouse IgM, κ
- Application: FC, ICC, WB
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC, Inhib, FuncS
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric (mouse/human) IgG1, κ
- Application: FC, ICC, WB
Compare
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: ELISA, FC, Inhib, FuncS
Compare
-
Compare
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: ELISA, FC, Inhib, FuncS
Compare
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC, Inhib, FuncS
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA, FC, Inhib, FuncS
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric (mouse/human) Fab
- Application: FC, ICC, WB
Compare
-
- Type: Mouse Fab
- Application: FC, ICC, WB
Compare
-
- Type: Mouse scFv
- Application: FC, ICC, WB
Compare
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Inhib, FuncS
Compare
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Inhib, FuncS
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA, FC, Inhib, FuncS
Compare
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, FC, Inhib, FuncS
Compare
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Globo H is a hexasaccharide and belongs to a large number of tumor-associated carbohydrate antigens that are overexpressed on the surface of various epithelial cancer cells, including breast, colon, ovarian, pancreatic, lung, and prostate cancer cells. The aberrant expression of Globo H renders it an attractive candidate for immunotherapy and the development of cancer vaccines for Globo H-positive cancers.